Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
“This expansion is a bold step forward for Mölnlycke in the U.S. It reinforces our mission to free patients and caregivers from the burden of wounds, strengthens supply resilience, and helps us to deliver high-quality wound care solutions faster, smarter, and more sustainably,” says Zlatko Rihter, CEO of Mölnlycke. “I’m proud to mark this milestone for Mölnlycke, for Maine and for the future of MedTech.”
The expansion is part of Mölnlycke’s strategic commitment to localise production and meet growing demand from U.S. healthcare providers. The state-of-the-art facility will support Mölnlycke’s long-term sustainability goals by using renewable energy solutions, including wind and solar power, and streamlined logistics. It will also feature advanced machinery sourced from U.S. suppliers.
Over the next five years, the investment will create new job opportunities, increasing Mölnlycke’s workforce in Maine by approximately 10%, and will engage local contractors and suppliers. Mölnlycke’s ambition with the Brunswick expansion, is to enable for more patients in the U.S. to benefit from cutting-edge innovative and high-quality wound care products produced by Mölnlycke.
“Today isn’t just about breaking ground. It’s about being bold, embracing partnerships and leading with passion,” says Chris Biddle, General Manager of U.S. Manufacturing, Wound Care. “Thank you to everyone who helped bring this vision to reality. The expansion is a win for Mölnlycke, for the local community and, ultimately, for the patients we serve.”
The groundbreaking ceremony was attended by senior federal and state lawmakers, including US Senator for Maine, Angus King, and Maine Governor, Janet Mills, who offered their support for the investment.
Note to editors
More information, including press materials and multimedia assets, is available in Mölnlycke’s online media room at Media room: Mölnlycke Brunswick, Maine site expansion
For more information, please contact:
Latest news
-
Mölnlycke recognised with EUPD’s ‘ESG Transparency Award
We are delighted to announce that Mölnlycke was recognised with ‘ESG Transparency Award' by EUPD Research. Mölnlycke achieved the highest excellence level with the total score of 95,5%.
-
Shaping wound care policy across Europe
We are proud to play our part in shaping the future of wound care in Europe. Mölnlycke has been elected one of the organisations leading the Wound Care Sector Working Group at MedTech Europe, the industry association representing medical technology across the continent.
-
2025 Future Summit by Mölnlycke Health Care
Smarter incision care and partnerships are key to enhanced clinical practise and improved patient outcomes.
-
Mölnlycke donates patent to spark innovation in sustainable healthcare
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.
-
Mölnlycke establishes first wound care manufacturing site in China
Changshu, China, and Gothenburg, Sweden. 5 November 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.
-
Mölnlycke Health Care’s global headquarters ranked number one workplace in Sweden and top 20 globally in Leesman workplace experience survey
Gothenburg, Sweden, 15 October 2025 Mölnlycke® Health Care is proud to announce that its global headquarters have placed number one in Sweden, and top 20 globally, in the prestigious Leesman® Index, a benchmark survey measuring workplace experience across thousands of organisations worldwide.
-
Media room: Mölnlycke Brunswick, Maine site expansion
-
High burnout among operating room staff poses significant risk to patient safety—new review reveals
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
-
Mölnlycke awarded second consecutive EcoVadis Platinum medal for sustainability performance
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.